世界肝炎日2026：打破障碍，向消除肝炎目标迈进_老虎社区_美港股上老虎

世界肝炎日2026：打破障碍，向消除肝炎目标迈进

关于腾盛博药

腾盛博药（股票代码：2137.HK）是一家生物技术公司，致力于针对重大未被满足的患者需求和治疗选择有限的领域开发疗法，以改善患者健康状况。公司正推进一系列独特的候选药物研发管线，包括进展最领先的针对乙型肝炎病毒（HBV）感染的项目。在富有远见卓识和经验丰富的领导团队带领下，公司在中国和美国均设有运营机构。欲了解更多信息，请点击阅读原文。

阅读原文

文章原文

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":590697269331152,"tweetId":"590697269331152","gmtCreate":1785200160000,"gmtModify":1785216994176,"author":{"id":4088222930030430,"idStr":"4088222930030430","authorId":4088222930030430,"authorIdStr":"4088222930030430","name":"腾盛博药2137HK","avatar":"https://static.tigerbbs.com/7225daebeee9c083bcbed970259d2446","vip":5,"userType":5,"introduction":"致力于服务患者需求,提升中国公共医疗保健水平","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4751,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/1ab22a34bf6945d1825dd0eaefff197a"},{"img":"https://static.tigerbbs.com/e148ac83f9934868a9b389caa2927b4c"},{"img":"https://static.tigerbbs.com/626099e5eaf14cad9694e627d1e82658"},{"img":"https://static.tigerbbs.com/d5d5177f7dd64c8ab174eb0cb754f6ab"},{"img":"https://static.tigerbbs.com/1c1e8445d7f74abb9b2c59c92121e6ee"},{"img":"https://static.tigerbbs.com/b79a9c9802314537a997f873e06c0573"},{"img":"https://static.tigerbbs.com/ea6a5562e487461abe2382f958bc3fe8"},{"img":"https://static.tigerbbs.com/5b859d6dea454b81bda939252586a0e0"}],"coverImages":[{"img":"https://static.tigerbbs.com/1ab22a34bf6945d1825dd0eaefff197a"},{"img":"https://static.tigerbbs.com/e148ac83f9934868a9b389caa2927b4c"},{"img":"https://static.tigerbbs.com/626099e5eaf14cad9694e627d1e82658"}],"title":"世界肝炎日2026：打破障碍，向消除肝炎目标迈进","html":"<html><head></head><body><div>\n <img src=\"https://static.tigerbbs.com/1ab22a34bf6945d1825dd0eaefff197a\">\n <img src=\"https://static.tigerbbs.com/e148ac83f9934868a9b389caa2927b4c\">\n <img src=\"https://static.tigerbbs.com/626099e5eaf14cad9694e627d1e82658\">\n <img src=\"https://static.tigerbbs.com/d5d5177f7dd64c8ab174eb0cb754f6ab\">\n <img src=\"https://static.tigerbbs.com/1c1e8445d7f74abb9b2c59c92121e6ee\">\n <img src=\"https://static.tigerbbs.com/b79a9c9802314537a997f873e06c0573\">\n 关于腾盛博药\n 腾盛博药（股票代码：2137.HK）是一家生物技术公司，致力于针对重大未被满足的患者需求和治疗选择有限的领域开发疗法，以改善患者健康状况。公司正推进一系列独特的候选药物研发管线，包括进展最领先的针对乙型肝炎病毒（HBV）感染的项目。在富有远见卓识和经验丰富的领导团队带领下，公司在中国和美国均设有运营机构。欲了解更多信息，请点击阅读原文。\n <img src=\"https://static.tigerbbs.com/ea6a5562e487461abe2382f958bc3fe8\">\n</div>\n \n<div>\n 阅读原文\n</div>\n \n 文章原文 \n <img src=\"https://static.tigerbbs.com/5b859d6dea454b81bda939252586a0e0\"></body></html>","htmlText":"<html><head></head><body><div>\n <img src=\"https://static.tigerbbs.com/1ab22a34bf6945d1825dd0eaefff197a\">\n <img src=\"https://static.tigerbbs.com/e148ac83f9934868a9b389caa2927b4c\">\n <img src=\"https://static.tigerbbs.com/626099e5eaf14cad9694e627d1e82658\">\n <img src=\"https://static.tigerbbs.com/d5d5177f7dd64c8ab174eb0cb754f6ab\">\n <img src=\"https://static.tigerbbs.com/1c1e8445d7f74abb9b2c59c92121e6ee\">\n <img src=\"https://static.tigerbbs.com/b79a9c9802314537a997f873e06c0573\">\n 关于腾盛博药\n 腾盛博药（股票代码：2137.HK）是一家生物技术公司，致力于针对重大未被满足的患者需求和治疗选择有限的领域开发疗法，以改善患者健康状况。公司正推进一系列独特的候选药物研发管线，包括进展最领先的针对乙型肝炎病毒（HBV）感染的项目。在富有远见卓识和经验丰富的领导团队带领下，公司在中国和美国均设有运营机构。欲了解更多信息，请点击阅读原文。\n <img src=\"https://static.tigerbbs.com/ea6a5562e487461abe2382f958bc3fe8\">\n</div>\n \n<div>\n 阅读原文\n</div>\n \n 文章原文 \n <img src=\"https://static.tigerbbs.com/5b859d6dea454b81bda939252586a0e0\"></body></html>","text":"关于腾盛博药 腾盛博药（股票代码：2137.HK）是一家生物技术公司，致力于针对重大未被满足的患者需求和治疗选择有限的领域开发疗法，以改善患者健康状况。公司正推进一系列独特的候选药物研发管线，包括进展最领先的针对乙型肝炎病毒（HBV）感染的项目。在富有远见卓识和经验丰富的领导团队带领下，公司在中国和美国均设有运营机构。欲了解更多信息，请点击阅读原文。 阅读原文 文章原文","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/590697269331152","repostId":0,"isVote":1,"tweetType":1,"viewCount":45331,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02137"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":342,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}